Office Headquarters: (610) 544-3500

perirx log in button

PeriRx Logo


Get News and Updates



CLIA: 39D2085645

PeriRx on Facebook PeriRx on YouTube PeriRx on Google+ Stephen M. Swanick LinkedIn


New York State has a separate and unique regulatory approval process for laboratory diagnostic testing. PeriRx is currently in the application process with our SaliMark™ OSCC test and is vigorously committed to pursuing this application approval. 

Monthly Archives: October 2014

Exclusive: Delco firm preparing to launch oral cancer screening test kit

swanick-martin-600xx4800-3200-0-20A Broomall, Pa., personalized medicine company is getting ready to launch its first product: a test kit for use in a dental office that can detect early-stage oral cancer from a small amount of saliva.

“We have no doubt this will save lives,” said Stephen M. Swanick, the chairman, CEO and founder of PeriRx. The company’s other initial investors are Dr. Neil Gottehrer, a practicing dentist; and Dr. Jack Martin, a cardiologist who is the company’s chief medical officer.

PeriRx plans to introduce SaliMark, its molecular DNA biomarker test to local dentists and hygienists at a free continuing-education course being held Nov. 6 in Havertown, Pa. The test kit will get a larger unveiling in December when it’s presented at the Greater New York Dental Meeting in New York City, a conference expected to draw 50,000 people including 25,000 dentists and 10,000 hygienists. [Read more…]